With our suite of solutions, de-risk and enhance clinical development and decision-making with the power of artificial intelligence.
Measure the likelihood of success for drugs across multiple therapeutic areas
Bolster internal risk identification with accurate AI-driven assessments
Pinpoint underlying drivers contributing to technical and regulatory risk
Explore risks influencing the drug development pipeline
Review the competitive landscape for acquisition, licensing and portfolio strategies
Detect predictive signals and optimize clinical trial design
Standardize risk evaluation processes across entire portfolios
Access a single source of quality, harmonized data for consistent risk evaluation
AI-Powered
Solutions Built With Comprehensive, Precise Data
Real-time tracking of clinical programs and features organized by proprietary ontologies
Expert data curation
and quality control by
biomedical professionals
Trusted by leading
pharma organizations
over legacy data sources
for PTRS/PoS calculations
Proven AI Accuracy With Advanced Algorithms
Accurate PTRS assessments validated retrospectively and prospectively at all clinical development stages
Actively tracked and validated real-world predictions
High prospective accuracy (>80%) vs. retrospective-only analyses of AI models
State-of-the-Art Explainable AI and Transparency
Transparency into PTRS predictions with hundreds of dimensions
Visualization of the drivers of PTRS predictions
Continuous innovation and investment with partner and customer feedback